Figures & data
Figure 1. Central nervous system infections due to brain-eating amoebae are challenging to treat with extremely poor prognosis. Re-purposing clinically used drugs for neuropathological conditions that are blood-brain barrier permeable, as well as parasite-specific compounds developed against related protozoa are potential avenues to design chemotherapeutics against orphan infections due to pathogenic free-living amoebae.
![Figure 1. Central nervous system infections due to brain-eating amoebae are challenging to treat with extremely poor prognosis. Re-purposing clinically used drugs for neuropathological conditions that are blood-brain barrier permeable, as well as parasite-specific compounds developed against related protozoa are potential avenues to design chemotherapeutics against orphan infections due to pathogenic free-living amoebae.](/cms/asset/b760a721-5529-4965-8364-12688bb0e649/ieod_a_2050368_f0001_oc.jpg)
Table 1. List of compounds targeting ergosterol